Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia.

Overview of attention for article published in Clinical Cancer Research, August 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 8 news stories from 8 outlets.

HealthDay News — For pediatric patients with acute myeloid leukemia (AML), a pharmacogenomics-based 10 single nucleotide…

Bei pädiatrischen Patienten mit akuter myeloischer Leukämie (AML) kann ein pharmakogenomischer 10-Einzelnukleotid-Polymorphismus…

Medically reviewed by Drugs.com. By Elana Gotkine HealthDay Reporter WEDNESDAY, Aug.

For pediatric patients with acute myeloid leukemia (AML), a pharmacogenomics-based 10 single nucleotide polymorphism cytarabine …

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.